• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Recursion Pharmaceuticals Inc Cl A (NQ: RXRX )

    6.730 -0.040 (-0.59%)
    Streaming Delayed Price Updated: 3:54 PM EDT, Aug 6, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Recursion Pharmaceuticals Inc Cl A

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    12 13 Next >
    Is Recursion Pharmaceuticals a Millionaire-Maker?
    It's likely to experience a lot of growth. 
    Via The Motley Fool
    Recursion to Report Second Quarter 2024 Business Updates and Financial Results on August 8th
    Company to host public L(earnings) call on August 8th at 5:00 pm ET / 3:00 pm MT 
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    99.9% of Nvidia's $380 Million Investment Portfolio Has Been Put to Work in These 4 Artificial Intelligence (AI)-Inspired Stocks
    Artificial intelligence (AI) colossus Nvidia has stakes in five publicly traded companies -- four of which account for almost every cent of its AI-driven portfolio. 
    Via The Motley Fool
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    AI-Focused Drug Discovery Stocks Portfolio Up 7% Last Week; Up 19% MTD
    The AI-powered drug discovery process is expected to grow by a CAGR of 30% by 2030. 
    Via Talk Markets
    Down About 47% This Year: Is Recursion Pharmaceuticals a Buy on the Dip?
    There's a lot to like about the company using automation and artificial intelligence to improve the new drug-discovery process. 
    Via The Motley Fool
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    25 Best Artificial Intelligence Stocks to Buy Right Now
    Artificial intelligence is revolutionizing industries across the board. These 25 companies span the spectrum, providing investors with a diversified basket of AI-centric equities. 
    Via The Motley Fool
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    These 7 AI Stocks Were Major Movers On Monday/Tuesday - Here's Why
    This article identifies the 
    Via Talk Markets
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    3 Millionaire-Maker Artificial Intelligence (AI) Stocks
    For the next stage of the AI era, companies with purposeful, practical, and highly targeted solutions stand to benefit the most. 
    Via The Motley Fool
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Clinical-Stage BioTech Drug Stocks Jumped 10% Last Week; UP 13% MTD
    The 10 clinical-stage AI-focused and psychedelic compound-based drug discovery companies in our Clinical-Stage BioTech Drug Stocks Portfolio are UP 12.8% MTD after having gone DOWN 13.2%, on average,... 
    Via Talk Markets
    Is Recursion Pharmaceuticals Stock a Buy?
    The company is ambitious and exploring exciting areas, but it's still early in the game. 
    Via The Motley Fool
    1 Reason to Buy Recursion Pharmaceuticals Stock and 2 Reasons to Sell
    This biotech is on the verge of a groundbreaking innovation, but it might not get over the hump. 
    Via The Motley Fool
    3 Healthcare Stocks Injecting AI for Big Gains
    Investors should keep a close eye on these AI healthcare stocks as they revolutionize the future of drug development and patient care. 
    Via InvestorPlace
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Bank of New York Mellon Posts Upbeat Earnings, Joins Archer Aviation, Rivian Automotive And Other Big Stocks Moving Higher On Friday
    Via Benzinga
    These Nvidia-Backed Artificial Intelligence (AI) Stocks Could Soar 73% to 89% Higher, According to Wall Street
    Are the analysts right about these Nvidia-backed AI stocks? 
    Via The Motley Fool
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Nvidia Is Buying Shares of These 5 AI Companies. Should You Do the Same?
    SoundHound AI, Arm, Nano-X, Recursion, and TuSimple are all in Nvidia's portfolio. 
    Via The Motley Fool
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    3 Longevity Stocks to Buy for Anti-Aging Breakthroughs
    Longevity stocks are at the forefront of combating age-related illnesses with transformative AI-driven drug discovery. 
    Via InvestorPlace
    Why SoundHound AI Stock Lost 22% Last Month
    Check out why SoundHound AI's stock dropped in June, despite a complete lack of negative news. Is this AI stock a great buy today? 
    Via The Motley Fool
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    3 Stocks This Amazon-Backed AI Says Will Turn $1K into $1M by 2030
    These high-risk, high-reward stocks have the potential to turn $1K into $1M by 2030, according to Amazon-backed AI Claude 3.5 Sonnet. 
    Via InvestorPlace
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Cathie Wood's Ark Invest Sells Tesla Shares Worth $14.5M Amid Rally Driven By Q2 Delivery Numbers, Picks Up Palantir Shares Again Today
    Via Benzinga
    Cathie Wood-Led Ark Invest Scoops Up $5.16M Worth Of Palantir Shares Amid Raging AI Fervor
    Via Benzinga
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Treasure Hunt: 3 Biotech Stocks Wall Street Hasn’t Discovered Yet
    Undiscovered biotech stocks can be risky but rewarding, especially when it involves mid-cap stocks with promise and no profit. 
    Via InvestorPlace
    Why Recursion Pharmaceuticals Stock Is Tumbling Thursday
    Recursion announced that it intends to offer and sell 30,769,230 shares of its common stock for $6.50 per share in an underwritten public offering. The clinical-stage biotech company also said it plans... 
    Via Benzinga
    Levi Strauss Posts Mixed Results, Joins Walgreens, AeroVironment And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
    Via Benzinga
    3 AI Stocks on the Edge of a Massive Surge
    Writers covering the AI stocks space agree on one thing: Nvidia’s dramatic rise is spawning a whole new wave of AI winners. 
    Via InvestorPlace
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    Pre-market stock movers are worth checking out on Thursday as we dig into all of the biggest news moving shares this morning! 
    Via InvestorPlace
    Recursion Announces Pricing of $200 Million Public Offering of Class A Common Stock
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    Recursion Pharmaceuticals Stock Is Diving Wednesday: What's Going On?
    After the market close on Wednesday, Recursion said it intends to offer and sell $200 million worth of its common stock in an underwritten public offering. All of the shares are being offered by... 
    Via Benzinga
    Recursion Announces Proposed Offering of Class A Common Stock
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    12 13 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.